Bioterrorism Rapid Response and Advanced Technology (BRRAT) Laboratory, Division of Preparedness and Emerging Infections (DPEI), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
J Clin Microbiol. 2012 Dec;50(12):3960-7. doi: 10.1128/JCM.02076-12. Epub 2012 Oct 3.
The clinical laboratory diagnosis of cutaneous anthrax is generally established by conventional microbiological methods, such as culture and directly straining smears of clinical specimens. However, these methods rely on recovery of viable Bacillus anthracis cells from swabs of cutaneous lesions and often yield negative results. This study developed a rapid protocol for detection of B. anthracis on clinical swabs. Three types of swabs, flocked-nylon, rayon, and polyester, were evaluated by 3 extraction methods, the swab extraction tube system (SETS), sonication, and vortex. Swabs were spiked with virulent B. anthracis cells, and the methods were compared for their efficiency over time by culture and real-time PCR. Viability testing indicated that the SETS yielded greater recovery of B. anthracis from 1-day-old swabs; however, reduced viability was consistent for the 3 extraction methods after 7 days and nonviability was consistent by 28 days. Real-time PCR analysis showed that the PCR amplification was not impacted by time for any swab extraction method and that the SETS method provided the lowest limit of detection. When evaluated using lesion swabs from cutaneous anthrax outbreaks, the SETS yielded culture-negative, PCR-positive results. This study demonstrated that swab extraction methods differ in their efficiency of recovery of viable B. anthracis cells. Furthermore, the results indicated that culture is not reliable for isolation of B. anthracis from swabs at ≥ 7 days. Thus, we recommend the use of the SETS method with subsequent testing by culture and real-time PCR for diagnosis of cutaneous anthrax from clinical swabs of cutaneous lesions.
皮肤炭疽的临床实验室诊断通常通过常规微生物学方法建立,例如培养和直接对临床标本的直接涂片进行染色。然而,这些方法依赖于从皮肤病变拭子中回收活炭疽杆菌细胞,并且经常产生阴性结果。本研究开发了一种快速检测临床拭子中炭疽杆菌的方法。通过 3 种提取方法,即拭子提取管系统(SETS)、超声处理和涡旋,评估了三种拭子类型,即绒毛尼龙、人造丝和聚酯。将有活力的炭疽杆菌细胞接种到拭子上,并通过培养和实时 PCR 比较这些方法随时间的效率。生存能力测试表明,SETS 从 1 天龄的拭子中获得了更多的炭疽杆菌回收;然而,在第 7 天,3 种提取方法的存活能力均降低,在第 28 天,存活能力均为阴性。实时 PCR 分析表明,任何拭子提取方法的时间均不会影响 PCR 扩增,并且 SETS 方法提供了最低的检测极限。当使用皮肤炭疽暴发的病变拭子时,SETS 得到了培养阴性、PCR 阳性的结果。本研究表明,拭子提取方法在回收有活力的炭疽杆菌细胞的效率上存在差异。此外,结果表明,培养法在≥7 天时从拭子中分离炭疽杆菌不可靠。因此,我们建议使用 SETS 方法,随后进行培养和实时 PCR 检测,以从皮肤病变的临床拭子中诊断皮肤炭疽。